Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Fentanyl Testing topic

No spam. Unsubscribe anytime.

Committee advances fentanyl‑testing bill for juvenile dependency cases amid sharp debate

Assembly Committee on Human Services · June 30, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Assembly Human Services Committee passed SB 1234 as amended to Appropriations to require juvenile courts to include fentanyl testing when risk indicators are present; supporters cited fatal child exposures, while drug policy groups warned of redundant, potentially disparate testing.

Sen. Maria Alvarado Gill presented SB 1234, the "Accountability Before Custody Act," asking that when a juvenile court identifies a risk of fentanyl or opioid use by a parent or guardian, fentanyl be included in drug testing the court already orders. She told the committee that a California Department of Public Health report found 15 children ages 5 and under died from fentanyl‑related causes in 2019–2023 and said the bill "ensures that when courts are already engaged in evaluating child safety, fentanyl is not overlooked in that process." (Sen. Alvarado Gill)

Survivors and family members described personal losses during testimony. Corinne Frostick, who identified herself as the grandmother of a child who died after parental relapse, said the bill "matters because private testing that does not include fentanyl can miss a serious risk to an innocent child." She urged the committee to approve the ABC approach and the package of committee amendments that narrow implementation to observable indicators (prior positive tests, credible statements, possession of paraphernalia, or a documented professional assessment).

Opponents said the bill risks redundant or biased application and could expand unnecessary court‑ordered testing. Greg Gardner of the Drug Policy Alliance acknowledged the tragedy survivors described but urged the committee to reject SB 1234, arguing courts already have authority to order testing and that a fentanyl‑specific trigger "invites inconsistent and biased application." Michael Hefty, representing Los Angeles dependency lawyers, suggested technical amendments to link testing to concrete evidentiary indicators used in adjudications.

After discussion and committee amendments intended to clarify risk indicators and implementation, the committee voted to pass SB 1234 as amended to the Assembly Appropriations Committee. The author and several members said the measure is intended to create consistent statewide practice rather than broaden court authority.

Looking ahead, the bill will be considered in Appropriations, where legislators are expected to scrutinize implementation costs and equity safeguards.